The in vivo data showed that oncolytic adenovirus AdKi67-DsRed, AdKi67-CCL5, AdKi67-C2, AdKi67-C3 or B7H3-CAR-T cell monotherapy had partially inhibited tumor growth. Here, C2 is linked to neoplasm.